Skip to main content.
kumc.edu
Home

Luke V. Selby, M.D., M.S., F.A.C.S.

Luke Selby portrait
Associate Professor, Surgery

Professional Background

Luke V. Selby, MD, MS, FACS, FSSO is a board-certified general surgeon and surgical oncologists and an Associate Professor of Surgery at the University of Kansas Cancer Center. His clinical practice is focused on cutaneous malignancies, soft tissue sarcoma, and small bowel tumors. He is a recipient of a Paul Calabresi K12 Career Development Award from the University of Kansas Cancer Center and the National Cancer Institute, where he serves as the Vice-Chair of the Melanoma – Sarcoma Disease Site Working Group and Co-Leads a working group within the Clinical Trials Office focused on increasing clinical trial in locoregional therapies. He is a member of the AJCC Soft Tissue Sarcoma Expert Panel revising the 9th edition of the AJCC staging system for soft tissue sarcoma. A graduate of general surgery residency at the University of Colorado and Complex General Surgical Oncology fellowship at The Ohio State University, Dr. Selby received teaching awards at both institutions.

Education and Training
  • MD, Medicine, New York Medical College, Valhalla, New York
  • MS, Health Policy and Economics, Weill Cornell Graduate School of Medical Science, New York, New York
  • Residency, Surgery, North Shore - LIJ Health System (now Northwell Health), Manhasset, NY
  • Post Doctoral Fellowship, Outcomes and Clinical Research, Memorial Sloan Kettering Cancer Center, New York, NY
  • Clinical Fellowship, Complex General Surgical Oncology, The Ohio State University and James Cancer Hospital, Columbus, OH
Professional Affiliations
  • Society of Surgical Oncology, Presidential Scholar Mentorship Program, Member, 2025 - Present
  • Society of Surgical Oncology, Sarcoma Disease-Site Working Group, Member, 2025 - Present
  • Society of Surgical Oncology, Abstract Reviewer, 2025 - Present
  • Society of Surgical Oncology, Fellow and Young Attending Committee, Member, 2023 - 2025
  • Transatlantic Australasian Retroperitoneal Sarcoma Working Group, RESAR Governance Committee, Member, 2023 - Present
  • Society of Surgical Oncology, Member, 2022 - 2022
Current Research and Grants
  • Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (MelMarT-II) (SWOG 2015), National Cancer Institute National Clinical Trials Network, Site-PI
  • Surgery With or Without Neoadjuvant Chemotherapy in High-Risk RetroPeritoneal Sarcoma (STRASS2), EORTC, Site-PI